P/E ratio for Qiagen (QGEN)
P/E ratio as of July 2025 (TTM): 119
According to Qiagen 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 119.241. At the end of 2024 the company had a P/E ratio of 121.
P/E ratio history for Qiagen from 2001 to 2025
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2024 | 121 | 334.9% |
| 2023 | 27.9 | 10.03% |
| 2022 | 25.3 | 8.63% |
| 2021 | 23.3 | -26.91% |
| 2020 | 31.9 | -118.28% |
| 2019 | -174 | -551.21% |
| 2018 | 38.7 | -76.83% |
| 2017 | 167 | 111.52% |
| 2016 | 78.9 | 65.77% |
| 2015 | 47.6 | 7.74% |
| 2014 | 44.2 | -41.6% |
| 2013 | 75.6 | 140.06% |
| 2012 | 31.5 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 28.4 | -76.20% | 🇺🇸 USA |
 Hologic HOLX | 27.6 | -76.85% | 🇺🇸 USA |
 Becton Dickinson BDX | 34.8 | -70.78% | 🇺🇸 USA |
 General Electric GE | 41.8 | -64.98% | 🇺🇸 USA |
 Bio-Techne TECH | 70.5 | -40.84% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.